Can statins improve outcomes after isolated cardiac valve surgery? A systematic literature review

Jacob Chacko1, Leanne Harling, Hutan Ashrafian

  • 1Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Clinical Cardiology
|May 15, 2013
PubMed

Insights

Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) show no clear benefit in isolated valve surgery outcomes. More research is needed to determine if statins alone improve patient results after valve replacement.

Area of Science:

  • Cardiovascular Surgery
  • Pharmacology
  • Clinical Outcomes

Background:

  • Statins are known to improve outcomes in coronary artery surgery.
  • The role of statins in isolated valve surgery (IVS) is not well-established.
  • Pleiotropic effects of statins may benefit patients undergoing IVS.

Purpose of the Study:

  • To investigate the role of statin therapy in bioprosthetic valve replacement.
  • To determine if statins confer a postoperative benefit in isolated valve surgery.

Main Methods:

  • Systematic review of the literature.
  • Inclusion of nine observational studies (7 retrospective, 2 prospective).
  • Analysis of data from 18,154 patients.

Main Results:

  • Nine studies involving 18,154 patients were analyzed.
  • The studies focused on statin therapy in bioprosthetic valve replacement.
  • Current evidence is insufficient to support routine statin use in IVS.

Conclusions:

  • Insufficient evidence exists to recommend routine statin therapy for isolated valve surgery.
  • Statin therapy may be considered if hypercholesterolemia or coronary artery disease is present.
  • Prospective studies are required to define optimal statin therapy for postoperative benefit.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...